X-linked myotubular myopathy mimics hereditary spastic paraplegia in two female manifesting carriers of pathogenic MTM1 variant.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 13 05 2020
revised: 20 07 2020
accepted: 13 08 2020
pubmed: 18 8 2020
medline: 1 5 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

X-linked myotubular myopathy (XLMTM) is a rare congenital myopathy caused by pathogenic variants in the myotubularin 1 (MTM1) gene. XLMTM leads to severe weakness in male infants and majority of them die in the early postnatal period due to respiratory failure. Disease manifestations in female carriers vary from asymptomatic to severe, generalized congenital weakness. The symptomatic female carriers typically have limb-girdle weakness, asymmetric muscle weakness and skeletal size, urinary incontinence, facial weakness, ptosis and ophthalmoplegia. Here we describe a Finnish family with two females with lower limb spasticity and hyperreflexia resembling spastic paraplegia, gait difficulties and asymmetric muscle weakness in the limbs. A whole exome sequencing identified a heterozygous pathogenic missense variant MTM1 c.1262G > A, p.(Arg421Gln) segregating in the family. The variant has previously been detected in male and female patients with XLMTM. Muscle biopsy of one of the females showed variation in the myofiber diameter, atrophic myofibers, central nuclei and necklace fibers consistent with a diagnosis of XLMTM. This report suggests association between spastic paraplegia and pathogenic MTM1 variants expanding the phenotypic spectrum potentially associated with XLMTM, but the possible association needs to be confirmed by additional cases.

Identifiants

pubmed: 32805447
pii: S1769-7212(20)30433-X
doi: 10.1016/j.ejmg.2020.104040
pii:
doi:

Substances chimiques

Protein Tyrosine Phosphatases, Non-Receptor EC 3.1.3.48
myotubularin EC 3.1.3.48

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104040

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Minna Kraatari (M)

PEDEGO Research Unit, Medical Research Center and Department of Clinical Genetics, University of Oulu and Oulu University Hospital, Oulu, Finland.

Hannu Tuominen (H)

Department of Pathology, Oulu University Hospital, Oulu, Finland.

Sari Tuupanen (S)

Blueprint Genetics, Espoo, Finland.

Tarja Haapaniemi (T)

Department of Neurology, Oulu University Hospital, Oulu, Finland.

Jukka Moilanen (J)

PEDEGO Research Unit, Medical Research Center and Department of Clinical Genetics, University of Oulu and Oulu University Hospital, Oulu, Finland.

Elisa Rahikkala (E)

PEDEGO Research Unit, Medical Research Center and Department of Clinical Genetics, University of Oulu and Oulu University Hospital, Oulu, Finland. Electronic address: elisa.rahikkala@ppshp.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH